NasdaqCM - Delayed Quote USD
HeartSciences Inc. (HSCS)
At close: 4:00 PM EDT
After hours: 4:12 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Oct 2024) | Next Qtr. (Jan 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -2.43 | -2.12 | -8.84 | -6.08 |
| Low Estimate | -2.56 | -2.41 | -9.82 | -8.35 |
| High Estimate | -2.3 | -1.84 | -7.86 | -3.81 |
| Year Ago EPS | -16 | -3 | -19 | -8.84 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Oct 2024) | Next Qtr. (Jan 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 350k | 500k | 1.65M | 2.1M |
| Low Estimate | -- | -- | 100k | 600k |
| High Estimate | 700k | 1M | 3.2M | 3.6M |
| Year Ago Sales | -- | 15k | 19k | 1.65M |
| Sales Growth (year/est) | -- | 3,233.30% | 8,584.20% | 27.30% |
Earnings History
| CURRENCY IN USD | 10/31/2023 | 1/31/2024 | 4/30/2024 | 7/31/2024 |
|---|---|---|---|---|
| EPS Est. | -12 | -6 | -3.5 | -2.46 |
| EPS Actual | -16 | -3 | -18.81 | -2.64 |
| Difference | -4 | 3 | -15.31 | -0.18 |
| Surprise % | -33.30% | 50.00% | -437.40% | -7.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Oct 2024) | Next Qtr. (Jan 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.43 | -2.12 | -8.84 | -6.08 |
| 7 Days Ago | -2.43 | -2.12 | -8.84 | -6.08 |
| 30 Days Ago | -2.43 | -2.12 | -8.84 | -6.08 |
| 60 Days Ago | -2.39 | -2.09 | -8.45 | -6.29 |
| 90 Days Ago | -2.28 | -2.42 | -8.43 | -3.81 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Oct 2024) | Next Qtr. (Jan 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HSCS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 84.80% | -- | -- | 5.10% |
| Next Qtr. | 29.30% | -- | -- | 11.80% |
| Current Year | 53.50% | -- | -- | 2.10% |
| Next Year | 31.20% | -- | -- | 12.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.68% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | Ascendiant Capital: Buy to Buy | 9/23/2024 |
| Initiated | Ascendiant Capital: Buy | 1/30/2023 |
| Maintains | Maxim Group: Buy | 12/19/2022 |
| Initiated | Maxim Group: Buy | 11/9/2022 |
| Initiated | Benchmark: Speculative Buy | 8/8/2022 |
Related Tickers
INBS Intelligent Bio Solutions Inc.
1.3900
+2.21%
AIMD Ainos, Inc.
0.4550
-2.78%
BBLG Bone Biologics Corporation
1.3000
-3.70%
SINT Sintx Technologies, Inc.
3.1200
-0.64%
OPGN OpGen, Inc.
1.7600
+5.39%
RSLS ReShape Lifesciences Inc.
5.88
+4.07%
AEMD Aethlon Medical, Inc.
0.3846
-0.88%
TBIO Telesis Bio, Inc.
1.3500
-0.74%
BJDX Bluejay Diagnostics, Inc.
0.0839
-3.01%
VVOS Vivos Therapeutics, Inc.
2.6800
+6.35%